The Latest Breaking News from HCM

The Chinese economy is showing signs of recovery as its economy grew faster than expectations. Moreover, proactive government measures are expected to stimulate further future economic growth. Amid this backdrop, investors could look to add fundamentally strong Chinese stocks: Trip.com Group (TCOM), HUTCHMED (China) (HCM), and JD.com (JD). Keep reading.

Despite the real estate industry crisis and other headwinds, the Chinese economy beats expectations to grow 5.3% in the first quarter, positioning it for future growth. Thus, top China stocks HUTCHMED (HCM), Autohome (ATHM), and Youdao (DAO) could be strong buys in May. Keep reading….

Workday, Inc (NASDAQ:WDAY) clocked 21.9% revenue growth in Q2 to $1.54 billion, which beat average analyst estimates. The subscription revenues of $1.37 billion were up 22.8%.  Workday reported EPS of $0.83, which beat average analyst estimates. Workday reported solid 2Q23 results highlighted with an uncertain macro backdrop pressuring sales much less than feared, Needham analyst…

According to a Bloomberg report, U.S. regulators could reportedly have full access to auditing reports from most of the 200-plus China-based companies listed in New York in mid-2022. In the drafting stage, the framework from the China Securities Regulatory Commission and other national agencies would let most Chinese firms keep their U.S.…

Hutchmed (China) Limited (NASDAQ:HCM) reported FY21 sales of $356.1 million, up 56% Y/Y, driven by commercial progress on three in-house developed oncology drugs Elunate, Sulanda, and Orpathys. FY21 Oncology/Immunology consolidated revenues reached $119.6 million, up 296%, in line with the guidance of $110-130 million. Elunate revenues increased 168% to $53.5 million. Sulanda…

The HCM (human capital management) software market is booming, due to digital transformation and hybrid working. Prominent companies in this space, Workday (WDAY) and Ceridian (CDAY), should therefore benefit. But which of these two stocks is a better buy now? Read more to find out.